A blood test picked up an abnormal protein, and now you are being watched rather than treated — here is what that monitoring looks for.
MGUS stands for monoclonal gammopathy of undetermined significance. It means a blood test found a protein made by one group of altered plasma cells, in a small amount, without the organ damage seen in myeloma. According to the Mayo Clinic, MGUS is not cancer, but it does raise the risk of plasma cell cancers and related conditions, which is why most people are monitored rather than treated.
This guide explains the words in the diagnosis, what raises the chance of having it, and what you can usefully do before you next sit down with your doctor.
What MGUS Means
Take the name apart. Monoclonal means many identical copies of one thing — here, one protein, made by one family of cells. Gammopathy means something unusual in a group of blood proteins. Of undetermined significance means the finding has been identified, but what it will mean for you over time is not settled.
The cells involved are plasma cells, a type of white blood cell that normally makes antibodies to fight infection. In MGUS, a group of these cells has genetic changes and makes copies of the same protein, called a monoclonal protein or M protein, which circulates in the blood. The Mayo Clinic describes MGUS as having a low amount of M protein and no myeloma-related organ damage — meaning no harm to bones, kidneys, or blood counts of the kind seen in multiple myeloma, a cancer of plasma cells.
M protein in blood is usually reported in grams per deciliter (g/dL); free light chains, smaller pieces of antibody, are reported in milligrams per deciliter (mg/dL) or as a ratio. Reference ranges differ between laboratories and can differ by age and kidney function, so read your result next to the range printed on your own report.
Mayo Clinic describes three main types — non-IgM MGUS, IgM MGUS, and light-chain MGUS — which differ in the type of monoclonal protein and in the conditions they are most likely to progress to. Most people with MGUS have no symptoms at all; the National Cancer Institute notes there is no standard screening for it and almost all cases are found by chance on blood tests done for something else.
The course varies by person. Mayo Clinic reports that most people with MGUS do not go on to develop a blood cancer, and that outlook depends partly on the type and amount of M protein and on free light chain results — so a single number for any one person does not apply. Your doctor or a hematologist, a doctor who specializes in blood conditions, is the person who can interpret your particular results.
Common Causes and Risk Factors
Mayo Clinic states that experts do not know exactly what causes MGUS: it begins when a group of plasma cells acquires genetic changes, but what triggers those changes is unknown in most people. The factors below are associations reported by Mayo Clinic, not a ranked list and not a cause in any individual.
- Age — cannot be changed. MGUS becomes more common with age: about 3% of people older than 50, about 5% of those older than 70, and 9% of those older than 85 (Mayo Clinic).
- Race and ancestry — cannot be changed. Black people and people of African descent have higher risk.
- Male sex at birth — cannot be changed.
- Family history of MGUS — cannot be changed.
- A weakened immune system — usually cannot be changed directly, though the underlying condition or medication is worth discussing with your doctor.
- Chemical exposures — sometimes changeable. Pesticides, asbestos, and fertilizers are listed among exposures linked to MGUS.
- Obesity — listed by Mayo Clinic among things you can change.
- Cigarette smoking — listed by Mayo Clinic among things you can change.
What to Do Before Your Next Appointment
1. Get your own copies of the results. Ask the ordering office or patient portal for the serum protein electrophoresis (SPEP), immunofixation, and serum free light chain reports — these are the tests used to find, identify, and measure M protein — and keep them in one folder. 2. Write down the date you were told and what was said. Note whether anyone mentioned a bone marrow biopsy, imaging, or a 24-hour urine test, since Mayo Clinic lists these among the follow-up tests used in higher-risk cases. 3. Start a short symptom log. Mayo Clinic lists bone pain, tiredness or weakness, unintended weight loss, fever with no known cause, frequent infections, tingling or numbness in the arms or legs, easy bruising or bleeding, trouble breathing, and confusion as symptoms to raise with a healthcare professional — write the date and what you noticed, in a few words. 4. Write the scheduling question down so you do not forget it. > Ask your doctor > "How often do I need to come back, and what tests do I need each time?" 5. Ask about lifestyle and referral in the same visit. Mayo Clinic suggests asking "Should I start treatment or change my lifestyle?", and you can add whether a referral to a hematologist is planned. 6. List your medications, supplements, and relevant family history. Bring the list on paper or on your phone so the visit is not spent reconstructing it.
Frequently asked questions
Is MGUS cancer?
No. Mayo Clinic states that MGUS is not cancer, but having it raises the risk of plasma cell cancers and related conditions, including multiple myeloma, lymphomas, Waldenstrom macroglobulinemia, and AL amyloidosis. Mayo Clinic reports that about 1% of people with MGUS develop one of these each year, and that the risk varies from person to person. Call your doctor the same day for new unexplained bone pain with weakness, a fever you cannot account for, or bruising and bleeding that is new for you, and go to an emergency department for sudden trouble breathing or new confusion.
Will I be given treatment?
Mayo Clinic states that MGUS itself does not require treatment, and that the care team instead schedules regular checkups with repeat blood and urine tests to look for any rise in M protein. A first follow-up exam is likely about six months after diagnosis, and the National Cancer Institute notes that current guidelines recommend annual follow-up blood tests for people with intermediate- or high-risk MGUS. Your own interval is a decision for your doctor, based on your test results.
How is MGUS different from smoldering myeloma?
Test results help the team separate MGUS from smoldering multiple myeloma (SMM) and from active multiple myeloma. Mayo Clinic describes SMM as having more altered plasma cells in the bone marrow or more monoclonal protein than MGUS, while still not causing the organ damage or other features of active myeloma. Which category you are in depends on the specific numbers on your reports, so ask which one your results fit and why.
Can MGUS go away on its own?
Sometimes. In a long-term study reported by Mayo Clinic, the M protein became undetectable without a known cause in about 2% of people with MGUS, and this was more common when the M protein level was very low at diagnosis. That outcome cannot be predicted for any one person, which is part of why repeat testing is used.
Does MGUS cause problems other than cancer?
Mayo Clinic links MGUS with a higher risk of osteoporosis — thinning of the bones — and fractures, a higher risk of viral and bacterial infections, especially of the nose, throat, and lungs, and a higher risk of blood clots in the veins. Tell your doctor about repeated chest infections or a new fracture from a minor fall. Sudden shortness of breath, chest pain, or pain and swelling in one calf can signal a clot and warrant emergency care.
